Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 2,691 |
|
|||||
| News | - | ||||||
| Day High | 2.1117 | Low High |
|||||
| Day Low | 2.09 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Dominari Holdings Inc | DOMH | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0341 | -1.60% | 2.10 | 09:00:33 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.09 | 2.09 | 2.1117 | 2.1341 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 19 | 2,691 | US$ 2.10 | US$ 5,664 | - | 1.76 - 3.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:00:18 | 2 | US$ 2.10 | USD |
Dominari Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.71M | 5.35M | - | 2.04M | -22.88M | -4.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Dominari News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DOMH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.03 | 2.2599 | 2.01 | 2.10 | 3,471 | 0.07 | 3.45% |
| 1 Month | 2.71 | 3.10 | 2.01 | 2.44 | 8,982 | -0.61 | -22.51% |
| 3 Months | 2.07 | 3.20 | 1.9165 | 2.54 | 12,516 | 0.03 | 1.45% |
| 6 Months | 1.94 | 3.20 | 1.85 | 2.39 | 12,240 | 0.16 | 8.25% |
| 1 Year | 2.41 | 3.40 | 1.76 | 2.50 | 11,716 | -0.31 | -12.86% |
| 3 Years | 3.21 | 4.45 | 1.76 | 3.01 | 15,725 | -1.11 | -34.58% |
| 5 Years | 3.21 | 4.45 | 1.76 | 3.01 | 15,725 | -1.11 | -34.58% |
Dominari Description
| Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. |
